BerandaALKS • NASDAQ
add
Alkermes Plc
Tutup sebelumnya
$26,55
Rentang hari
$26,07 - $26,72
Rentang tahun
$25,56 - $36,45
Kapitalisasi pasar
4,31Â M USD
Volume Rata-Rata
2,06Â jt
Rasio P/E
12,65
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 390,66Â jt | -2,12% |
Biaya operasional | 248,22Â jt | 8,98% |
Laba bersih | 87,10Â jt | -4,66% |
Margin laba bersih | 22,30 | -2,58% |
Penghasilan per saham | 0,68 | -3,04% |
EBITDA | 100,80Â jt | -13,51% |
Tarif pajak efektif | 16,92% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,02Â M | 15,94% |
Total aset | 2,25Â M | 2,08% |
Total liabilitas | 628,22Â jt | -31,92% |
Total ekuitas | 1,62 M | — |
Saham yang beredar | 165,08 jt | — |
Harga terhadap nilai buku | 2,70 | — |
Tingkat pengembalian aset | 10,72% | — |
Tingkat pengembalian modal | 14,16% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 87,10Â jt | -4,66% |
Kas dari operasi | 150,20Â jt | 2,86% |
Kas dari investasi | -29,21Â jt | -156,34% |
Kas dari pembiayaan | 405,00Â rb | 100,49% |
Perubahan kas bersih | 121,39Â jt | 6,12% |
Arus kas bebas | 115,42Â jt | -42,08% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
1.800
